While Ethicon’s devices for the procedure have included a warning about the spread of cancerous cells, it has decided to suspend the devices until such time as the FDA clearly defines the risks associated with morcellation, according to the report.
“At Ethicon, our first priority is to our customers and patients,” a company spokesman told the Enquirer.
More Articles on Quality:
5 Tips for Focusing Infection Control Policies
10 Things to Know About Infection Control
ASCA Encourages AHRQ ASC Patient Safety Program Participation
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
